Valproic Acid
Product Images NDC 67544-479

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 67544-479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 250mg (67544 479)

Bottle Label 250mg (67544 479)
Label for Valproic Acid 250 mg capsules, containing 90 capsules. The label includes the NDC number 67544-0479-60 and states the product is repackaged by Aphena Pharma Solutions - Tennessee, LLC, with manufacturing by Catalent Pharma Solutions Inc in St. Petersburg, FL. Storage instructions specify 20-25°C (68-77°F) and dispensing in a tight light-resistant container. The label indicates the product is RX only.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Valproic 01)

Chemical Structure (Valproic 01)
Chemical structure of Valproic Acid showing the arrangement of carbon, hydrogen, and oxygen atoms with branching in the alkyl chain and a carboxylic acid functional group.*
FDA Label Image

Figure 1 (Valproic 02)

Figure 1 (Valproic 02)
A cumulative distribution curve chart comparing % reduction in CPS rate versus % of patients. It contrasts Divalproex sodium delayed-release tablets USP (solid line) with placebo (dotted line), showing rates of improvement and worsening among patients.*
FDA Label Image

Figure 2 (Valproic 03)

Figure 2 (Valproic 03)
This line graph depicts the percentage reduction in CPS rate (y-axis) versus the percentage of patients (x-axis) for Valproic Acid. The graph compares two groups: high dose (solid line) and low dose (dashed line). The y-axis also indicates improvement above zero and worsening below zero, with no change at the zero line.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.